S. V. Nalyotov, O. S. Nalyotova, M. M. Alesinskiy, I. A. Korovka, E. N. Nalyotova, T. Tverdokhleb
{"title":"高血压患者抗高血压药物治疗的各种选择的药物经济学方面","authors":"S. V. Nalyotov, O. S. Nalyotova, M. M. Alesinskiy, I. A. Korovka, E. N. Nalyotova, T. Tverdokhleb","doi":"10.33920/med-03-2209-05","DOIUrl":null,"url":null,"abstract":"The paper presents a pharmacoeconomic assessment of treatment costs and cost-effectiveness when using various options for antihypertensive pharmacotherapy (AHPT) in patients with hypertension. Purpose of the study: to conduct a comparative pharmacoeconomic analysis of the standard antihypertensive pharmacotherapy and the therapy including quercetin or dihydroquercetin, in patients with hypertension","PeriodicalId":406478,"journal":{"name":"Glavvrač (Chief Medical Officer)","volume":"293 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pharmacoeconomic aspects of various options for antihypertensive pharmacotherapy in patients with hypertension\",\"authors\":\"S. V. Nalyotov, O. S. Nalyotova, M. M. Alesinskiy, I. A. Korovka, E. N. Nalyotova, T. Tverdokhleb\",\"doi\":\"10.33920/med-03-2209-05\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The paper presents a pharmacoeconomic assessment of treatment costs and cost-effectiveness when using various options for antihypertensive pharmacotherapy (AHPT) in patients with hypertension. Purpose of the study: to conduct a comparative pharmacoeconomic analysis of the standard antihypertensive pharmacotherapy and the therapy including quercetin or dihydroquercetin, in patients with hypertension\",\"PeriodicalId\":406478,\"journal\":{\"name\":\"Glavvrač (Chief Medical Officer)\",\"volume\":\"293 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-08-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Glavvrač (Chief Medical Officer)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33920/med-03-2209-05\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Glavvrač (Chief Medical Officer)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33920/med-03-2209-05","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Pharmacoeconomic aspects of various options for antihypertensive pharmacotherapy in patients with hypertension
The paper presents a pharmacoeconomic assessment of treatment costs and cost-effectiveness when using various options for antihypertensive pharmacotherapy (AHPT) in patients with hypertension. Purpose of the study: to conduct a comparative pharmacoeconomic analysis of the standard antihypertensive pharmacotherapy and the therapy including quercetin or dihydroquercetin, in patients with hypertension
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
